Givaudan SA (OTCMKTS:GVDNY – Get Free Report) has been assigned an average rating of “Hold” from the nine research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating on the company.
A number of analysts recently weighed in on the stock. Jefferies Financial Group lowered shares of Givaudan from a “buy” rating to a “hold” rating in a research report on Tuesday, September 1st. Citigroup reissued a “neutral” rating on shares of Givaudan in a research note on Friday, September 25th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Givaudan in a research report on Thursday, September 3rd. Sanford C. Bernstein initiated coverage on shares of Givaudan in a research report on Wednesday, July 22nd. They issued a “strong sell” rating for the company. Finally, Barclays upgraded shares of Givaudan from an “equal weight” rating to an “overweight” rating in a research note on Monday, October 5th.
Get Our Latest Analysis on GVDNY
Givaudan Stock Down 0.4%
OTCMKTS GVDNY opened at $96.91 on Friday. Givaudan has a 52 week low of $65.97 and a 52 week high of $97.40. The company has a fifty day moving average of $83.43 and a two-hundred day moving average of $79.42.
About Givaudan
Givaudan is a Swiss company that develops and produces flavors, fragrances and related ingredients for consumer and industrial products. Its solutions are used in a broad range of applications, including foods and beverages, fine fragrances, personal care products, household goods and oral care.
The company operates through two principal areas: Taste & Wellbeing, which provides flavors, taste-modulation solutions, natural extracts and functional ingredients; and Fragrance & Beauty, which develops fragrances, fragrance ingredients, cosmetic ingredients and active beauty solutions.
Featured Stories
- Five stocks we like better than Givaudan
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
